The RNA Nanotechnology conference took place 01-04 August 2016 in the beautiful Wokefield Park Estate in Berkshire, UK. Chaired by scientific organiser, Dr. Peixuan Guo (Sylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery Systems, Ohio State University), the meeting looked at various aspects of RNA Nanotechnology, including biophysical approaches, RNA nanoparticle structure, nanoimmunology and… Continue reading De Gruyter Open Report – RNA Nanotechnology 2016
Neglected diseases continue to cause significant morbidity and mortality in the developing world. Of 850 new therapeutic products approved between 2000 and 2011, only 4% (and only 1% of all approved NCEs) were indicated for neglected diseases, even though these diseases account for 11% of the global disease burden. To help support the effort to… Continue reading Optibrium CEO to speak at Fusion’s 2017 drug discovery conference on supporting neglected diseases
Fusion Conferences are offering the chance for local cancer researchers to attend the Novel Concepts in the Biology and Treatment of Metastatic Cancer and Cancer Metabolism and the Tumour Microenvironment conferences, based in Paphos, Cyprus, for a reduced rate. The Metastatic Cancer conference, chaired by top experts in the field Dr. Jonathan Sleeman (University of Heidelberg),… Continue reading Special £450 rate for local cancer & oncology researchers
Dr. Michael Lisanti and Dr. Federica Sotgia are pleased to offer a fantastic opportunity to attend the forthcoming Cancer Metabolism and the Tumour Microenvironment: Importance of Inflammation and Stromal Cells conference. Fusion Conferences have 4 x £750 grants available to attend the conference, to be used against the registration fee only. Join Drs Lisanti and… Continue reading Grants for Cancer Metabolism conference
Fusion Conferences and the Chairs of RNA Nanotechnology have introduced a Special Student Rate for their conference in on 01-04 August 2016.